MLA Places Keren Tenenbaum as General Counsel, U.S. at Vifor Pharma

Hanover, MD (September 14, 2021) — Major, Lindsey & Africa (MLA), the world’s leading legal search firm, today announced the placement of Keren Tenenbaum as general counsel, U.S. at Vifor Pharma. The search was conducted by Tanja Albers, partner in Amsterdam; Amy Katz, managing director in Boston; and Pamela Salling, director in Basking Ridge, all with MLA’s In-House Counsel Recruiting group.

Keren will serve as a strategic legal advisor and essential member of the U.S. business and global legal leadership teams, providing strategic legal direction and support for all U.S. operations and managing the U.S. legal and compliance teams. She will partner closely with the global compliance team and have oversight of a wide range of US legal and compliance matters, including commercial, clinical, regulatory, medical and HR legal issues arising from the sale, marketing/promotion and distribution of pharmaceutical products, labor/employment, litigation, commercial business transactions and general corporate governance matters.

Vifor Pharma Group is a global pharmaceuticals company, headquartered in Switzerland, focused on iron deficiency, nephrology and cardio-renal therapies. Vifor Pharma Group strives to help patients around the world with severe and chronic diseases lead better, healthier lives by developing, manufacturing and marketing pharmaceutical products for precision patient care.

“We were thrilled to partner with Vifor on their search for a new legal executive in the U.S. Not only is Keren an extremely engaging and accomplished pharma attorney with deep legal and regulatory experience, but her passion, energy and commitment to helping patients will be a perfect fit for Vifor,” said Amy Katz. “We are excited to see what Keren accomplishes and contributes to Vifor and are eager to follow Keren and Vifor’s anticipated success over the coming months and years,” added Pamela Sailing.

Keren most recently served as vice president and assistant general counsel for Bausch Health Companies, where she led the legal function for Salix Pharmaceuticals, a gastroenterology-focused pharmaceutical company. Prior to Bausch, she spent nearly a decade with Pfizer, Inc., where she held roles of increasing scope and responsibility, including as the global legal lead for the patient and health impact (PHI) business unit and as global product counsel for several key brands. Before going in-house, Keren was a litigator with both DLA Piper, where she handled complex FCPA investigations in multiple foreign jurisdictions as well as major class-action litigations, and a boutique litigation firm, Newman and Greenberg. She began her legal career in Israel as a prosecutor before moving to the US to serve in a legal/political role with the Mission to United Nations. Keren earned her LL.M. from Columbia University School of Law, her M.A. in Criminal Justice from Rutgers University and her LL.B. from The College of Management Academic Studies in Rishon LeZion, Israel.